IndustryPRwire

IndustryPRwire is a B2B content publisher. Publish your Market research Press Releases to generate quality leads as well as gain worldwide and local exposure.

[IndustryPRwire @IndustryPRwire]

Philips signs multiyear strategic partnership agreement for connected care solutions with 28-hospital Dutch SAZ group
https://t.co/aVhQCb3M2U

[IndustryPRwire @IndustryPRwire]

GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
https://t.co/yxjVtrKAMK

[IndustryPRwire @IndustryPRwire]

BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System

https://t.co/9K2FNR0hrt

[IndustryPRwire @IndustryPRwire]

Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation
https://t.co/DCa49UHnLp

[IndustryPRwire @IndustryPRwire]

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc
https://t.co/p4dCHjUpHM

[IndustryPRwire @IndustryPRwire]

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing
https://t.co/2JuIWm7UIp

[IndustryPRwire @IndustryPRwire]

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals
https://t.co/eJkgp0GDgu
#Covid19

[IndustryPRwire @IndustryPRwire]

Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine
https://t.co/AJDXUQlHsA
#Covid19

[IndustryPRwire @IndustryPRwire]

KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Use Disorder
https://t.co/uThMV6itCC

[IndustryPRwire @IndustryPRwire]

BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.
https://t.co/m4fwg2Xr8o

[IndustryPRwire @IndustryPRwire]

Protolabs Completes Acquisition of 3D Hubs
https://t.co/xGmd1ZvdWc

[IndustryPRwire @IndustryPRwire]

Roche renews partnership with Sysmex to deliver haematology testing solutions
https://t.co/6SGJIgaeMg

[IndustryPRwire @IndustryPRwire]

New Clinical Data Shows BD Antigen Test May Be More Selective In Detecting Infectious COVID-19 Patients Than Molecular Tests
https://t.co/wJnJw7cF38

[IndustryPRwire @IndustryPRwire]

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
https://t.co/IC76DzbM0q

[IndustryPRwire @IndustryPRwire]

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical
https://t.co/rHpbS4yUDZ

[IndustryPRwire @IndustryPRwire]

Recipharm signs manufacturing agreement with Enzymatica
https://t.co/1yRqZtpbVC

[IndustryPRwire @IndustryPRwire]

POINT Biopharma signs exclusive license agreement with CanProbe for the commercialization of a neuroendocrine tumor treatment
https://t.co/dOWDsVWmJT

[IndustryPRwire @IndustryPRwire]

STERIS Announces Definitive Agreement to Acquire Cantel Medical
https://t.co/8yD6c5uZ5q

[IndustryPRwire @IndustryPRwire]

Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
https://t.co/0oSK6oZ4RE

[IndustryPRwire @IndustryPRwire]

Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals
https://t.co/OClfeAw7GI